● Recruiting

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Condition: Overweight or Obese Adults · Overweight or Obese, Type 2 Diabetes · Sponsor: Alveus Therapeutics, Inc.

PhasePhase 1

Planned participants180

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

A Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants with or without Type 2 Diabetes

This description comes directly from the study's public registry record.

Talk to the study team

Study Director · +1 215-607-2243 · clinicaltrials@alveustx.com

Always discuss trial participation with your own doctor first.

Locations (2)

Clinical Pharmacology of Miami	Miami, Florida, United States	Recruiting
Ohio Clinical Trials	Columbus, Ohio, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07399678